These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

600 related items for PubMed ID: 18382329

  • 1. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
    Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, Nagane M.
    Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
    [Abstract] [Full Text] [Related]

  • 2. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells.
    Kim DK, Kim IJ, Hwang S, Kook JH, Lee MC, Shin BA, Bae CS, Yoon JH, Ahn SG, Kim SA, Kanai Y, Endou H, Kim JK.
    Neurosci Res; 2004 Dec; 50(4):437-46. PubMed ID: 15567481
    [Abstract] [Full Text] [Related]

  • 3. System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line.
    Yamauchi K, Sakurai H, Kimura T, Wiriyasermkul P, Nagamori S, Kanai Y, Kohno N.
    Cancer Lett; 2009 Apr 08; 276(1):95-101. PubMed ID: 19058911
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma.
    Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Nakajima T, Mori M.
    Lung Cancer; 2009 Oct 08; 66(1):120-6. PubMed ID: 19171406
    [Abstract] [Full Text] [Related]

  • 5. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.
    Nawashiro H, Otani N, Shinomiya N, Fukui S, Ooigawa H, Shima K, Matsuo H, Kanai Y, Endou H.
    Int J Cancer; 2006 Aug 01; 119(3):484-92. PubMed ID: 16496379
    [Abstract] [Full Text] [Related]

  • 6. Expression and functional characterization of the system L amino acid transporter in KB human oral epidermoid carcinoma cells.
    Yoon JH, Kim YB, Kim MS, Park JC, Kook JK, Jung HM, Kim SG, Yoo H, Ko YM, Lee SH, Kim BY, Chun HS, Kanai Y, Endou H, Kim DK.
    Cancer Lett; 2004 Mar 18; 205(2):215-26. PubMed ID: 15036654
    [Abstract] [Full Text] [Related]

  • 7. Platelet-derived growth factor stimulates LAT1 gene expression in vascular smooth muscle: role in cell growth.
    Liu XM, Reyna SV, Ensenat D, Peyton KJ, Wang H, Schafer AI, Durante W.
    FASEB J; 2004 Apr 18; 18(6):768-70. PubMed ID: 14977877
    [Abstract] [Full Text] [Related]

  • 8. Lysophosphatidylcholine enhances cytokine production of endothelial cells via induction of L-type amino acid transporter 1 and cell surface antigen 4F2.
    Takabe W, Kanai Y, Chairoungdua A, Shibata N, Toi S, Kobayashi M, Kodama T, Noguchi N.
    Arterioscler Thromb Vasc Biol; 2004 Sep 18; 24(9):1640-5. PubMed ID: 15178563
    [Abstract] [Full Text] [Related]

  • 9. L-type amino acid transporter 1-mediated L-leucine transport at the inner blood-retinal barrier.
    Tomi M, Mori M, Tachikawa M, Katayama K, Terasaki T, Hosoya K.
    Invest Ophthalmol Vis Sci; 2005 Jul 18; 46(7):2522-30. PubMed ID: 15980244
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of system L (LAT1/CD98hc) reduces the growth of cultured human breast cancer cells.
    Shennan DB, Thomson J.
    Oncol Rep; 2008 Oct 18; 20(4):885-9. PubMed ID: 18813831
    [Abstract] [Full Text] [Related]

  • 11. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.
    Fan X, Ross DD, Arakawa H, Ganapathy V, Tamai I, Nakanishi T.
    Biochem Pharmacol; 2010 Sep 15; 80(6):811-8. PubMed ID: 20510678
    [Abstract] [Full Text] [Related]

  • 12. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
    Bian XW, Yang SX, Chen JH, Ping YF, Zhou XD, Wang QL, Jiang XF, Gong W, Xiao HL, Du LL, Chen ZQ, Zhao W, Shi JQ, Wang JM.
    Neurosurgery; 2007 Sep 15; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
    [Abstract] [Full Text] [Related]

  • 13. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
    Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Kawashima O, Iijima H, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.
    Pathol Res Pract; 2008 Sep 15; 204(8):553-61. PubMed ID: 18440724
    [Abstract] [Full Text] [Related]

  • 14. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
    Janpipatkul K, Suksen K, Borwornpinyo S, Jearawiriyapaisarn N, Hongeng S, Piyachaturawat P, Chairoungdua A.
    Cell Signal; 2014 Aug 15; 26(8):1668-79. PubMed ID: 24726839
    [Abstract] [Full Text] [Related]

  • 15. High expression of L-type amino acid transporter 1 in infiltrating glioma cells.
    Nawashiro H, Otani N, Uozumi Y, Ooigawa H, Toyooka T, Suzuki T, Katoh H, Tsuzuki N, Ohnuki A, Shima K, Shinomiya N, Matsuo H, Kanai Y.
    Brain Tumor Pathol; 2005 Aug 15; 22(2):89-91. PubMed ID: 18095110
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer.
    Imai H, Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, Sunaga N, Ishizuka T, Nagamori S, Promchan K, Nakajima T, Yamamoto N, Mori M, Kanai Y.
    Anticancer Res; 2010 Dec 15; 30(12):4819-28. PubMed ID: 21187458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.